1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

HealthCor Management, L.P. Buys Edwards Lifesciences Corp, Humana Inc, Elanco Animal Health Inc, Sells Zimmer Biomet Holdings Inc, Allergan PLC, Haemonetics Corp

New York, NY, based Investment company HealthCor Management, L.P. (Current Portfolio) buys Edwards Lifesciences Corp, Humana Inc, Elanco Animal Health Inc, Bristol-Myers Squibb Company, Abbott Laboratories, sells Zimmer Biomet Holdings Inc, Allergan PLC, Haemonetics Corp, DexCom Inc, Medtronic PLC during the 3-months ended 2019Q2, according to the most recent filings of the investment company, HealthCor Management, L.P.. As of 2019Q2, HealthCor Management, L.P. owns 50 stocks with a total value of $2.6 billion. These are the details of the buys and sells.

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of HealthCor Management, L.P.
  1. Neurocrine Biosciences Inc (NBIX) - 2,371,390 shares, 7.79% of the total portfolio. Shares added by 56.41%
  2. Humana Inc (HUM) - 644,860 shares, 6.65% of the total portfolio. Shares added by 149.81%
  3. Edwards Lifesciences Corp (EW) - 622,230 shares, 4.47% of the total portfolio. New Position
  4. Merck & Co Inc (MRK) - 1,292,410 shares, 4.22% of the total portfolio. Shares added by 2.83%
  5. Madrigal Pharmaceuticals Inc (MDGL) - 1,032,270 shares, 4.21% of the total portfolio. Shares added by 15.73%
New Purchase: Edwards Lifesciences Corp (EW)

HealthCor Management, L.P. initiated holding in Edwards Lifesciences Corp. The purchase prices were between $167.22 and $193.23, with an estimated average price of $181.16. The stock is now traded at around $222.01. The impact to a portfolio due to this purchase was 4.47%. The holding were 622,230 shares as of .

New Purchase: Elanco Animal Health Inc (ELAN)

HealthCor Management, L.P. initiated holding in Elanco Animal Health Inc. The purchase prices were between $31.11 and $34.79, with an estimated average price of $32.44. The stock is now traded at around $27.26. The impact to a portfolio due to this purchase was 3.79%. The holding were 2,879,010 shares as of .

New Purchase: Bristol-Myers Squibb Company (BMY)

HealthCor Management, L.P. initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $44.62 and $49.34, with an estimated average price of $46.57. The stock is now traded at around $47.63. The impact to a portfolio due to this purchase was 3.55%. The holding were 2,012,650 shares as of .

New Purchase: Amarin Corp PLC (AMRN)

HealthCor Management, L.P. initiated holding in Amarin Corp PLC. The purchase prices were between $16.27 and $20.51, with an estimated average price of $18.3. The stock is now traded at around $15.43. The impact to a portfolio due to this purchase was 2.3%. The holding were 3,047,910 shares as of .

New Purchase: Align Technology Inc (ALGN)

HealthCor Management, L.P. initiated holding in Align Technology Inc. The purchase prices were between $268.08 and $331.08, with an estimated average price of $301.8. The stock is now traded at around $174.50. The impact to a portfolio due to this purchase was 2.19%. The holding were 205,510 shares as of .

New Purchase: Charles River Laboratories International Inc (CRL)

HealthCor Management, L.P. initiated holding in Charles River Laboratories International Inc. The purchase prices were between $123.4 and $148.55, with an estimated average price of $135.54. The stock is now traded at around $129.43. The impact to a portfolio due to this purchase was 2.01%. The holding were 364,413 shares as of .

Added: Humana Inc (HUM)

HealthCor Management, L.P. added to a holding in Humana Inc by 149.81%. The purchase prices were between $232.89 and $276.48, with an estimated average price of $253.55. The stock is now traded at around $294.42. The impact to a portfolio due to this purchase was 3.99%. The holding were 644,860 shares as of .

Added: Abbott Laboratories (ABT)

HealthCor Management, L.P. added to a holding in Abbott Laboratories by 857.70%. The purchase prices were between $72.88 and $85, with an estimated average price of $78.62. The stock is now traded at around $84.54. The impact to a portfolio due to this purchase was 3.35%. The holding were 1,144,160 shares as of .

Added: Neurocrine Biosciences Inc (NBIX)

HealthCor Management, L.P. added to a holding in Neurocrine Biosciences Inc by 56.41%. The purchase prices were between $72.24 and $91.27, with an estimated average price of $82.02. The stock is now traded at around $97.03. The impact to a portfolio due to this purchase was 2.81%. The holding were 2,371,390 shares as of .

Added: Nevro Corp (NVRO)

HealthCor Management, L.P. added to a holding in Nevro Corp by 377.73%. The purchase prices were between $58.04 and $66.99, with an estimated average price of $62.27. The stock is now traded at around $83.00. The impact to a portfolio due to this purchase was 2.45%. The holding were 1,227,730 shares as of .

Added: HCA Healthcare Inc (HCA)

HealthCor Management, L.P. added to a holding in HCA Healthcare Inc by 185.63%. The purchase prices were between $112.01 and $135.18, with an estimated average price of $126.22. The stock is now traded at around $123.19. The impact to a portfolio due to this purchase was 1.43%. The holding were 419,330 shares as of .

Added: Vertex Pharmaceuticals Inc (VRTX)

HealthCor Management, L.P. added to a holding in Vertex Pharmaceuticals Inc by 58.94%. The purchase prices were between $164.61 and $190.37, with an estimated average price of $174.67. The stock is now traded at around $183.72. The impact to a portfolio due to this purchase was 1.42%. The holding were 538,440 shares as of .

Sold Out: Zimmer Biomet Holdings Inc (ZBH)

HealthCor Management, L.P. sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $112.14 and $128.84, with an estimated average price of $120.53.

Sold Out: Allergan PLC (AGN)

HealthCor Management, L.P. sold out a holding in Allergan PLC. The sale prices were between $115.73 and $167.43, with an estimated average price of $138.45.

Sold Out: DexCom Inc (DXCM)

HealthCor Management, L.P. sold out a holding in DexCom Inc. The sale prices were between $111.38 and $155.66, with an estimated average price of $125.45.

Sold Out: Intuitive Surgical Inc (ISRG)

HealthCor Management, L.P. sold out a holding in Intuitive Surgical Inc. The sale prices were between $458.27 and $585.89, with an estimated average price of $513.67.

Sold Out: Icon PLC (ICLR)

HealthCor Management, L.P. sold out a holding in Icon PLC. The sale prices were between $129.99 and $153.97, with an estimated average price of $140.11.

Sold Out: Thermo Fisher Scientific Inc (TMO)

HealthCor Management, L.P. sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $257.51 and $295.55, with an estimated average price of $275.13.



Here is the complete portfolio of HealthCor Management, L.P.. Also check out:

1. HealthCor Management, L.P.'s Undervalued Stocks
2. HealthCor Management, L.P.'s Top Growth Companies, and
3. HealthCor Management, L.P.'s High Yield stocks
4. Stocks that HealthCor Management, L.P. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)